Perrussel, Marc
Arakelyan, Zaruhi https://orcid.org/0009-0006-2491-9654
Funding for this research was provided by:
LEO Pharma
Article History
Received: 4 February 2025
Accepted: 17 April 2025
First Online: 18 May 2025
Declarations
:
: Dr Marc Perrussel has previously been provided with financial assistance by Abbott, Abbvie, AMGEN, BMS, Celgène, Genevrier, Lilly, Janssen, LEOPharma, Merck-Serono, Novartis, Sanofi, Schering-Plough, UCB, and Wyeth-Pfizer. Dr Zaruhi Arakelyan has no conflicts of interest to declare.
: Ethical approval by an institutional review board was not applicable to this study according to French legislation. All patients in this manuscript have given oral informed consent for participation in the case series and the use of their deidentified, anonymized, aggregated data and their case details for publication. Local governance procedures, including the collection and storage of non-identifiable patient data, were followed and adhered to. The research was conducted in accordance with the Declaration of Helsinki.